MetaCap

Windward Bio Group AG Company Profile

NASDAQ: WWBHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

24.29+0.275 (+1.15%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Windward Bio Group at a glance

Windward Bio Group AG (NASDAQ: WWB) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector headquartered in Basel, Switzerland. Windward Bio Group is led by Dr. Luca Santarelli M.D. and employs about 33 people. The company's shares have traded publicly since 2026.

At a market capitalization of $1.43 billion, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0002145089, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Windward Bio Group do?

Windward Bio Group AG operates as a clinical stage biotechnology company that develops ultra-long-acting antibody medicines for patients with respiratory and dermatologic diseases. Its drug candidates WIN378, an ultra-long-acting and novel fully human monoclonal antibody, which has completed Phase I clinical study that inhibits thymic stromal lymphopoietin (TSLP); and WIN027, an ultra-long-acting bispecific antibody that is in Phase I clinical study simultaneously targets TSLP and interleukin-13 (IL-13) and two clinically validated drivers of inflammatory disease. The company has collaboration agreements with Sichuan Kelun-Biotech BioPharmaceutical Co., Ltd, Harbour BioMed (Shanghai) Co., Ltd, and Qyuns Therapeutics Co., Ltd. Windward Bio Group AG was incorporated in 2024 and is based in Basel, Switzerland.

Business description based on the company's public filings.

Company information

Legal name
Windward Bio Group AG
Ticker
NASDAQ: WWB
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
CEO
Dr. Luca Santarelli M.D.
Employees
33
Headquarters
Aeschenplatz 6, Basel, Switzerland
Phone
41 61 551 75 75
IPO year
2026
SEC CIK
0002145089

Companies similar to Windward Bio Group

WWB peer companies
CompanyPrice% ChgMarket capCompare
MESOMesoblast Limited ADR10.89-2.59%$1.41Bvs WWB
ALVOAlvotech4.12-3.96%$1.47Bvs WWB
IMCRImmunocore Holdings plc ADR26.41-0.83%$1.36Bvs WWB
RXRXRecursion Pharmaceuticals Inc. Class A2.45-9.93%$1.53Bvs WWB
VIRVir Biotechnology Inc.8.39-5.41%$1.56Bvs WWB
NVAXNovavax Inc.7.47-3.24%$1.23Bvs WWB
TSHATaysha Gene Therapies Inc.3.72-1.33%$1.21Bvs WWB
VORVor Biopharma Inc.19.19+3.62%$1.18Bvs WWB

Related